Dr.Reddy's, RDIF commence clinical trials for Sputnik V Vaccine in India
Image Credit: shortpedia
Dr.Reddys Laboratories Ltd. and the Russian Direct Investment Fund (RDIF) on Tuesday announced commencement of adaptive phase 2 and 3 clinical trials for COVID-19 vaccine Sputnik V in India after receiving necessary clearance from the Central Drugs Laboratory, Kasauli in Himachal Pradesh. The Indian drug maker, in a release, said this will be a multicenter and randomized controlled study, which will include safety and immunogenicity study.